MAIA
MAIA Biotechnology, Inc.
-0.01 (-1.07%)1.39USD382K成交股數84.2M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 5.6M | 44K | −12.2M | 6.4M | 3.1M | 3.2M | 2.7M | 2.1M | 2.3M | 3.7M | 2.6M | 2.6M |
| 銷售管理費用 | 2.7M | 3.4M | 2.4M | 3.0M | 2.1M | 2.2M | 1.5M | 1.8M | 1.6M | 2.7M | 2.4M | 2.1M |
| 營業利益 | −8.3M+61% | −6.9M+28% | −4.3M+3% | −9.4M+145% | −5.2M+31% | −5.4M-15% | −4.2M-15% | −3.8M-18% | −3.9M | −6.4M | −5.0M | −4.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −7.9M+49% | −6.4M+41% | −3.6M+33% | −8.9M+0% | −5.3M-34% | −4.5M-28% | −2.7M-44% | −8.9M+96% | −8.1M | −6.3M | −4.9M | −4.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.13-28% | -0.14-12% | -0.09-18% | -0.27-32% | -0.18-61% | -0.16-60% | -0.11-69% | -0.40+14% | -0.46 | -0.40 | -0.36 | -0.35 |
| 稀釋股數 | 60.8M | 45.2M | 32.1M | 33.2M | 30.3M | 27.7M | 23.9M | 22.2M | 17.6M | 13.3M | 13.7M | 12.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 28.2M | 35.3M | 9.7M | 11.8M | 11.0M | 11.9M | 9.2M | 12.0M | 8.7M | 7.6M | 7.0M | 10.3M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 7.6M | 7.6M | 7.3M | 11.7M | 7.2M | 6.9M | 7.6M | 8.9M | 14.5M | 7.1M | 4.3M | 3.4M |
| 股東權益 | 20.7M | 27.8M | 2.4M | 42K | 3.9M | 4.9M | 1.6M | 3.2M | −5.8M | 478K | 2.7M | 6.9M |
| 負債比 | 26.8% | 21.4% | 75.5% | 99.6% | 64.9% | 58.3% | 82.5% | 73.7% | 166.1% | 93.7% | 60.8% | 33.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −5.3M+26% | – | – | – | −4.2M | – | – | −3.6M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −22.4M | –% | -0.70 | – |
| FY2024 | 0.00 | – | −23.3M | –% | -1.05 | – |
| FY2023 | 0.00 | – | −19.8M | –% | -1.49 | – |
| FY2022 | 0.00 | – | −15.8M | –% | -1.75 | – |
| FY2021 | – | – | −12.6M | –% | -2.37 | – |